This study examined potent and selective BELSOMRA, human orexin receptor (OX1R and OX2R) high antagonist developed as an oral remedy for insomnia. Results show that BELSOMRA has an effect on both symptomatic improvement of sleep maintenance and sleep onset and drug resistance is not seen by long-term administration, and there was generally good tolerance.